TScan Therapeutics Inc (TCRX): TScan presenting at 5th Annual Evercore...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	30
Posts	4347
Boards Moderated	0
Alias Born	03/20/2011

FACT-MASTER

Re: None

Tuesday, 11/22/2022 4:34:43 PM

Tuesday, November 22, 2022 4:34:43 PM

TScan presenting at 5th Annual Evercore ISI HealthCONx Conference:

https://www.biospace.com/article/releases/tscan-therapeutics-to-participate-in-the-5th-annual-evercore-isi-healthconx-conference/

"

Published: Nov 22, 2022

WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that management will participate in a virtual fireside chat at the 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022 at 10:55 a.m. ET.

A webcast of the fireside chat will be available on the “Events and Presentations” section of the Company’s website at ir.tscan.com. An archived replay of the webcast will be available on the Company’s website for 90 days following the event."